The role of EphA2 in KRAS mutant non-small cell lung cancer

被引：0
|
作者：
Amato, Katherine [1 ]
Wang, Shan [1 ]
Hastings, Andrew [1 ]
Chen, Haiying [2 ]
Colvin, Daniel [1 ]
Ye, Fei [1 ]
Chen, Jin [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
[2] Univ Melbourne, Melbourne, Vic, Australia
来源：
MOLECULAR CANCER RESEARCH | 2014年 / 12卷
关键词：
D O I：
10.1158/1557-3125.RASONC14-A01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A01
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The role of EphA2 in the maintenance of cell viability of KRAS mutant non-small cell lung cancer.
    Amato, katherine R.
    Chen, Jin
    CANCER RESEARCH, 2013, 73 (08)
  • [2] EphA2 in the Early Pathogenesis and Progression of Non-Small Cell Lung Cancer
    Brannan, Jennifer M.
    Sen, Banibrata
    Saigal, Babita
    Prudkin, Ludmila
    Behrens, Carmen
    Solis, Luisa
    Dong, Wenli
    Bekele, B. Nebiyou
    Wistuba, Ignacio
    Johnson, Faye M.
    CANCER PREVENTION RESEARCH, 2009, 2 (12) : 1039 - 1049
  • [3] EphA2 expression in non-small cell lung cancers
    LeGolvan, MP
    DeLellis, RA
    Khanna, P
    Chin, YE
    Wang, L
    MODERN PATHOLOGY, 2006, 19 : 312A - 312A
  • [4] EphA2 expression in non-small cell lung cancers
    LeGolvan, MP
    DeLellis, RA
    Khanna, P
    Chin, YE
    Wang, L
    LABORATORY INVESTIGATION, 2006, 86 : 312A - 312A
  • [5] EphA2 expression and brain relapse in resected non-small cell lung cancer
    Goodgame, Boone
    Brantley-Sieders, Dana
    Waqar, Atif
    Zhang, Jean
    Chen, Jin
    Watson, Mark
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S906 - S907
  • [6] A role of nicotinamide phosphoribosyltransferase in growth of KRAS mutant non-small cell lung cancer
    Okumura, Shunsuke
    Sasaki, Takaaki
    Ohsaki, Yoshinobu
    CANCER RESEARCH, 2015, 75
  • [7] EphA2 targeted intratumoral therapy for non-small cell lung cancer using albumin mesospheres
    Lee, Hung-Yen
    Mohammed, Kamal A.
    Kaye, Fredric
    Moudgil, Brij M.
    Nasreen, Najmunnisa
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (07): : 3293 - 3303
  • [8] Is CRAF required for the maintenance of KRAS mutant non-small cell lung cancer?
    Russell, P.
    Wickenden, J.
    Cadwallader, K.
    Maguire, S.
    Joel, J.
    Stockdale, M.
    Chicas, A.
    Banka, D.
    Darman, R.
    Perino, S.
    Fekkes, P.
    Smith, P.
    Zhu, P.
    Buonamici, S.
    Moore, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 171 - 171
  • [9] KRAS in non-small cell lung cancer
    Amanam, I.
    Gupta, R.
    Mambetsariev, I.
    Koczywas, M.
    Cristea, M.
    Massarelli, E.
    Reckamp, K. L.
    Salgia, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Clinical Implications of Expression of EphA2 and PRMT1 in Non-Small Cell Lung Cancer Patients
    Zhang, Sheng
    Qiu, Rui
    Lv, Zhiping
    Yang, Liying
    He, Wei
    PAKISTAN JOURNAL OF ZOOLOGY, 2024, 56 (03) : 1497 - 1500
12345